SEI Medical PCL (BKK:SEI) Beneish M-Score: -1.49 (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SEI SEI Medical PCL BKK:SEI
19 GF Score
Price ฿1.78
! 3 Warning Signs
View Full Analysis

What is SEI Medical PCL Beneish M-Score?

SEI Medical PCL BKK:SEI -1.66% 19 Beneish M-Score is -1.49 as of Jul. 23, 2026. GuruFocus rates BKK:SEI with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 113 Medical Distribution companies, SEI Medical PCL ranks worse than 87.61% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.49 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for SEI Medical PCL's Beneish M-Score or its related term are showing as below:

BKK:SEI' s Beneish M-Score Range Over the Past 10 Years
Min: -3.25   Med: -2.45   Max: -1.49
Current: -1.49

During the past 4 years, the highest Beneish M-Score of SEI Medical PCL was -1.49. The lowest was -3.25. And the median was -2.45.


SEI Medical PCL Beneish M-Score Historical Data

* Premium members only.

The historical data trend for SEI Medical PCL's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SEI Medical PCL Beneish M-Score Chart

SEI Medical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 0.00 -2.38

SEI Medical PCL Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -3.25 -2.51 -2.38 -1.49

BKK:SEI vs MCK, CAH, COR: Beneish M-Score Comparison

For the Medical Distribution subindustry, SEI Medical PCL's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SEI Medical PCL Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, SEI Medical PCL's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SEI Medical PCL's Beneish M-Score falls into.


BKK:SEI
19GF Score
SEI Medical PCL BKK:SEI
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SEI Medical PCL Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SEI Medical PCL for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1889+0.528 * 0.9712+0.404 * 3.1747+0.892 * 0.781+0.115 * 1.2016
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.4621+4.679 * 0.043627-0.327 * 0.9882
=-1.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ฿101.5 Mil.
Revenue was 100.204 + 92.73 + 107.552 + 102.29 = ฿402.8 Mil.
Gross Profit was 38.539 + 34.658 + 40.435 + 30.749 = ฿144.4 Mil.
Total Current Assets was ฿400.6 Mil.
Total Assets was ฿520.0 Mil.
Property, Plant and Equipment(Net PPE) was ฿58.7 Mil.
Depreciation, Depletion and Amortization(DDA) was ฿16.2 Mil.
Selling, General, & Admin. Expense(SGA) was ฿104.5 Mil.
Total Current Liabilities was ฿179.6 Mil.
Long-Term Debt & Capital Lease Obligation was ฿10.3 Mil.
Net Income was 7.769 + 5.654 + 10.758 + 7.905 = ฿32.1 Mil.
Non Operating Income was 0.02 + -0.266 + 0.081 + 1.563 = ฿1.4 Mil.
Cash Flow from Operations was -9.965 + -11.2 + 11.839 + 17.329 = ฿8.0 Mil.
Total Receivables was ฿109.4 Mil.
Revenue was 147.106 + 116.248 + 128.777 + 123.593 = ฿515.7 Mil.
Gross Profit was 50.423 + 37.122 + 51.572 + 40.423 = ฿179.5 Mil.
Total Current Assets was ฿447.7 Mil.
Total Assets was ฿504.3 Mil.
Property, Plant and Equipment(Net PPE) was ฿38.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ฿13.4 Mil.
Selling, General, & Admin. Expense(SGA) was ฿91.6 Mil.
Total Current Liabilities was ฿170.2 Mil.
Long-Term Debt & Capital Lease Obligation was ฿16.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(101.537 / 402.776) / (109.354 / 515.724)
=0.252093 / 0.21204
=1.1889

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(179.54 / 515.724) / (144.381 / 402.776)
=0.348132 / 0.358465
=0.9712

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (400.637 + 58.696) / 519.977) / (1 - (447.695 + 38.092) / 504.314)
=0.116628 / 0.036737
=3.1747

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=402.776 / 515.724
=0.781

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(13.362 / (13.362 + 38.092)) / (16.183 / (16.183 + 58.696))
=0.259688 / 0.216122
=1.2016

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(104.547 / 402.776) / (91.559 / 515.724)
=0.259566 / 0.177535
=1.4621

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10.345 + 179.607) / 519.977) / ((16.254 + 170.17) / 504.314)
=0.365308 / 0.369659
=0.9882

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(32.086 - 1.398 - 8.003) / 519.977
=0.043627

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SEI Medical PCL has a M-score of -1.49 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.49 mean?
SEI Medical PCL (BKK:SEI) has a Beneish M-Score of -1.49 as of Jul. 23, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SEI Medical PCL and its competitors. According to the industry distribution chart, SEI Medical PCL ranks #99 out of 113 companies in the Medical Distribution industry, placing it in the top 87.6%.
Is SEI Medical PCL's Beneish M-Score too high?
SEI Medical PCL's current Beneish M-Score is -1.49. Based on the distribution chart, SEI Medical PCL ranks #99 out of 113 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, SEI Medical PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SEI Medical PCL's Beneish M-Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SEI Medical PCL ranks #99 out of 113 companies for Beneish M-Score. This places SEI Medical PCL in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SEI Medical PCL and its competitors. SEI Medical PCL's current Beneish M-Score is -1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SEI Medical PCL stock overvalued right now?
SEI Medical PCL (BKK:SEI) has a current Beneish M-Score of -1.49. The current Beneish M-Score is -1.49. SEI Medical PCL's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For SEI Medical PCL (BKK:SEI), the current Beneish M-Score is -1.49 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SEI Medical PCL Business Description

Address Ratchadaphisek Road, No. 546 Ratchada One Building, 7th Floor, Chankasem, Chatuchak District, Bangkok, THA, 10900
SEI Medical PCL operates in the medical equipment and scientific products industry as a distributor and service provider of medical equipment. It has three reportable segments which are the sales of equipment related to scientific instruments and medical equipment, the related service segment and the medical equipment disposal segment. The main geographic which the company operates is Thailand. Key revenue is collected from the Disposal Segment.
19GF Score

Get the complete analysis for BKK:SEI

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.78
Price